These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus. Falzarano D; Feldmann F; Grolla A; Leung A; Ebihara H; Strong JE; Marzi A; Takada A; Jones S; Gren J; Geisbert J; Jones SM; Geisbert TW; Feldmann H J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1082-9. PubMed ID: 21987745 [TBL] [Abstract][Full Text] [Related]
31. Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine. Medaglini D; Siegrist CA Curr Opin Virol; 2017 Apr; 23():88-94. PubMed ID: 28460340 [TBL] [Abstract][Full Text] [Related]
32. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein. Wilson JA; Hart MK J Virol; 2001 Mar; 75(6):2660-4. PubMed ID: 11222689 [TBL] [Abstract][Full Text] [Related]
33. EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain. Marzi A; Robertson SJ; Haddock E; Feldmann F; Hanley PW; Scott DP; Strong JE; Kobinger G; Best SM; Feldmann H Science; 2015 Aug; 349(6249):739-42. PubMed ID: 26249231 [TBL] [Abstract][Full Text] [Related]
34. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA. Ewer K; Rampling T; Venkatraman N; Bowyer G; Wright D; Lambe T; Imoukhuede EB; Payne R; Fehling SK; Strecker T; Biedenkopf N; Krähling V; Tully CM; Edwards NJ; Bentley EM; Samuel D; Labbé G; Jin J; Gibani M; Minhinnick A; Wilkie M; Poulton I; Lella N; Roberts R; Hartnell F; Bliss C; Sierra-Davidson K; Powlson J; Berrie E; Tedder R; Roman F; De Ryck I; Nicosia A; Sullivan NJ; Stanley DA; Mbaya OT; Ledgerwood JE; Schwartz RM; Siani L; Colloca S; Folgori A; Di Marco S; Cortese R; Wright E; Becker S; Graham BS; Koup RA; Levine MM; Volkmann A; Chaplin P; Pollard AJ; Draper SJ; Ballou WR; Lawrie A; Gilbert SC; Hill AV N Engl J Med; 2016 Apr; 374(17):1635-46. PubMed ID: 25629663 [TBL] [Abstract][Full Text] [Related]
35. Generation and epitope mapping of a monoclonal antibody against nucleoprotein of Ebola virus. Wang X; Liu Y; Wang H; Shi Z; Zhao F; Wei J; Shao D; Ma Z Sheng Wu Gong Cheng Xue Bao; 2012 Nov; 28(11):1317-27. PubMed ID: 23457784 [TBL] [Abstract][Full Text] [Related]
37. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs. Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816 [TBL] [Abstract][Full Text] [Related]
38. Construction and evaluation of DNA vaccine encoding Ebola virus glycoprotein fused with lysosome-associated membrane protein. Liu Y; Sun B; Pan J; Feng Y; Ye W; Xu J; Lan M; Sun H; Zhang X; Sun Y; Yang S; Shi J; Zhang F; Cheng L; Jiang D; Yang K Antiviral Res; 2021 Sep; 193():105141. PubMed ID: 34274417 [TBL] [Abstract][Full Text] [Related]
39. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals. Wong G; Richardson JS; Cutts T; Qiu X; Kobinger GP Antiviral Res; 2015 Apr; 116():17-9. PubMed ID: 25596432 [TBL] [Abstract][Full Text] [Related]